0.97
Schlusskurs vom Vortag:
$0.9003
Offen:
$0.8905
24-Stunden-Volumen:
74,593
Relative Volume:
0.42
Marktkapitalisierung:
$43.42M
Einnahmen:
$80.28M
Nettoeinkommen (Verlust:
$-38.83M
KGV:
-1.1661
EPS:
-0.8318
Netto-Cashflow:
$-28.67M
1W Leistung:
+8.98%
1M Leistung:
+12.79%
6M Leistung:
-15.65%
1J Leistung:
-28.68%
Tela Bio Inc Stock (TELA) Company Profile
Firmenname
Tela Bio Inc
Sektor
Branche
Telefon
484-320-2930
Adresse
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
TELA
Tela Bio Inc
|
0.97 | 40.30M | 80.28M | -38.83M | -28.67M | -0.8318 |
|
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Eingeleitet | Lake Street | Buy |
| 2019-12-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2019-12-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-03 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Tela Bio Inc Aktie (TELA) Neueste Nachrichten
TELA Stock Price, Quote & Chart | TELA BIO INC (NASDAQ:TELA) - ChartMill
Canaccord Genuity Maintains TELA Bio (TELA) Buy Recommendation - MSN
TELA Bio | 8-K: Current report - Moomoo
TELA Bio Expands Europe Sales as U.S. Growth Slows - MyChesCo
TELA Bio Inc. (TELA) Edges Lower, Tests Key Support After 2.7% DeclineUser Trade Ideas - Newser
Tela Bio Eyes Second-Half Ramp After Mixed Quarter - TipRanks
TELA Bio (TELA) Q1 2026 Results Miss Estimates — EPS $-0.21 vs $-0.19Retail Earnings Report - Newser
TELA Bio Healthcare Story Faces New Market Scrutiny - Kalkine Media
TELA Bio (NASDAQ: TELA) holder reports 2.44M shares, 5.5% stake - Stock Titan
Analysts Have Been Trimming Their TELA Bio, Inc. (NASDAQ:TELA) Price Target After Its Latest Report - simplywall.st
Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25 - Yahoo Finance
About Us | Oil & Gas JournalTELA Bio, Inc.Common stock (Nasdaq:TELA) Stock Quote - FinancialContent
Becton Dickinson stock (US0718131099): Antitrust case survives dismissal - AD HOC NEWS
TELA Bio, Inc. (TELA) reports Q1 loss, beats revenue estimates - MSN
Lake Street Keeps Their Buy Rating on TELA Bio (TELA) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), UnitedHealth (UNH) and TELA Bio (TELA) - The Globe and Mail
Tela Bio Earnings Call Balances Momentum and Risk - TipRanks
TELA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Becton Hernia Mesh Antitrust Case Survives Dismissal - Law360
TELA Bio (NASDAQ: TELA) Q1 2026 revenue edges up as net loss widens - Stock Titan
TELA outlines at least 8% 2026 revenue growth while guiding Q2 revenue to about $20.0M - MSN
Q1 2026 TELA Bio Inc Earnings Call Transcript - GuruFocus
TELA Bio revenue up 3% to USD 19.1M in Q1 2026 - Medical Buyer
TELA Bio, Inc. (NASDAQ:TELA) Q1 2026 Earnings Call Transcript - Insider Monkey
TELA Bio, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
TELA Bio Inc (TELA) Q1 2026 Earnings Call Highlights: Strong Eur - GuruFocus
TELA Bio, Inc. (TELA) Q1 2026 Earnings Call Transcript Summary - Moomoo
Is TELA Bio (TELA) a Possible Value Trap After Q1 2026? EPS Not - GuruFocus
TELA Bio Backs FY26 Revenue Guidance of at Least 8% Growth Over FY25 >TELA - Moomoo
Earnings call transcript: Tela Bio Q1 2026 earnings miss sparks stock dip By Investing.com - Investing.com South Africa
Tela Bio earnings missed by $0.05, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Tela Bio Q1 2026 earnings miss sparks stock dip - Investing.com Australia
TELA Bio Q1 2026 Earnings Call Transcript - Benzinga
TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
TELA Bio posts modest Q1 growth, maintains 2026 outlook - TipRanks
TELA Bio (NASDAQ:TELA) Reports Mixed Q1 Results with Revenue Beat but Wider Loss and Cautious Q2 Guidance - ChartMill
TELA Bio Reports First Quarter 2026 Financial Results - The Manila Times
TELA Bio Q1 revenue growth beats estimates, loss widens - TradingView
TELA Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
TELA Bio, Inc. Provides Revenue Guidance for the Second Quarter 2026 and Reiterates Revenue Guidance for the Full Year 2026 - marketscreener.com
What To Expect From TELA Bio Inc (TELA) Q1 2026 Earnings - GuruFocus
TELA Q1'26 Earnings: EPS estimate is (0.18) USD - TradingView
TELA Bio Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Why TELA Bio (TELA) could be the turning point you've been waiting for (Moonwalks) 2026-05-08Buy Signals - newser.com
TELA Bio (TELA) shares surge 11% after beating Q4 earnings estimates, defying analyst pessimism.Earnings Risk - newser.com
Earnings Preview: TELA Bio to Report Financial Results Post-market on May 12 - Moomoo
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio Plans Board Overhaul, Reports Preliminary Q1 Revenue Beat - MyChesCo
TELA Bio (TELA) posts narrower than expected Q4 2025 loss, sending shares up 4.59 percent in today’s trading.Convertible Notes - newser.com
Finanzdaten der Tela Bio Inc-Aktie (TELA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):